adamantylamide-alanyl-isoglutamine and Haemophilus Infections

adamantylamide-alanyl-isoglutamine has been researched along with Haemophilus Infections in 1 studies

*Haemophilus Infections: Infections with bacteria of the genus HAEMOPHILUS. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, PD; Bertot, GM; Grinstein, S; Guzmán, CA	1

Other Studies

1 other study(ies) available for adamantylamide-alanyl-isoglutamine and Haemophilus Infections

Article	Year
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7 Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Bronchoalveolar Lavage Fluid; Dipeptides; Female; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C; Otitis Media; Recombinant Proteins; Saliva; Vagina	2004

Article

Year

Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.

The Journal of infectious diseases, 2004, Apr-01, Volume: 189, Issue:7

Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Bronchoalveolar Lavage Fluid; Dipeptides; Female; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunization; Lung Diseases; Mice; Mice, Inbred BALB C; Otitis Media; Recombinant Proteins; Saliva; Vagina

2004